Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)
China
· Delayed Price · Currency is CNY 18.65
0.00 (0.00%)
Apr 29, 2026, 3:04 PM CST
SHE:300482 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 8,664 | 9,174 | 10,709 | 13,338 | 14,088 | 17,522 | Upgrade
|
| Market Cap Growth | -21.52% | -14.33% | -19.71% | -5.32% | -19.60% | -42.68% | Upgrade
|
| Enterprise Value | 7,223 | 8,219 | 9,278 | 12,063 | 13,309 | 16,889 | Upgrade
|
| Last Close Price | 18.65 | 19.75 | 22.00 | 29.19 | 30.33 | 37.19 | Upgrade
|
| PE Ratio | - | - | 19.07 | 27.35 | 11.77 | 27.62 | Upgrade
|
| Forward PE | 20.35 | 18.44 | 14.64 | 21.86 | 12.49 | 19.74 | Upgrade
|
| PS Ratio | 4.64 | 4.40 | 3.49 | 4.82 | 2.48 | 5.21 | Upgrade
|
| PB Ratio | 1.55 | 1.68 | 1.90 | 2.89 | 3.11 | 5.00 | Upgrade
|
| P/TBV Ratio | 1.68 | 1.81 | 2.05 | 3.17 | 3.50 | 5.65 | Upgrade
|
| P/FCF Ratio | 15.66 | 57.89 | 246.19 | - | 12.82 | 84.06 | Upgrade
|
| P/OCF Ratio | 10.44 | 19.81 | 29.61 | 40.58 | 8.38 | 26.35 | Upgrade
|
| EV/Sales Ratio | 3.46 | 3.94 | 3.03 | 4.36 | 2.34 | 5.03 | Upgrade
|
| EV/EBITDA Ratio | 70.13 | 84.32 | 11.05 | 17.01 | 8.48 | 20.66 | Upgrade
|
| EV/EBIT Ratio | - | - | 15.72 | 26.41 | 10.05 | 26.61 | Upgrade
|
| EV/FCF Ratio | 13.06 | 51.86 | 213.29 | - | 12.11 | 81.03 | Upgrade
|
| Debt / Equity Ratio | 0.11 | 0.11 | 0.11 | 0.13 | 0.17 | 0.17 | Upgrade
|
| Debt / EBITDA Ratio | - | 5.84 | 0.70 | 0.82 | 0.48 | 0.69 | Upgrade
|
| Debt / FCF Ratio | 1.10 | 3.80 | 13.92 | - | 0.70 | 2.79 | Upgrade
|
| Net Debt / Equity Ratio | -0.24 | -0.27 | -0.28 | -0.34 | -0.34 | -0.28 | Upgrade
|
| Net Debt / EBITDA Ratio | 93.58 | -15.38 | -1.90 | -2.23 | -0.98 | -1.21 | Upgrade
|
| Net Debt / FCF Ratio | -2.46 | -9.46 | -36.60 | 15.20 | -1.39 | -4.74 | Upgrade
|
| Asset Turnover | 0.27 | 0.30 | 0.47 | 0.46 | 1.02 | 0.73 | Upgrade
|
| Inventory Turnover | 2.89 | 2.84 | 3.12 | 2.77 | 6.99 | 3.66 | Upgrade
|
| Quick Ratio | 2.61 | 2.83 | 4.11 | 5.86 | 2.55 | 2.70 | Upgrade
|
| Current Ratio | 3.22 | 3.18 | 4.61 | 6.68 | 2.94 | 3.27 | Upgrade
|
| Return on Equity (ROE) | -3.04% | -1.25% | 11.01% | 10.65% | 29.60% | 19.47% | Upgrade
|
| Return on Assets (ROA) | -2.09% | -1.15% | 5.71% | 4.73% | 14.84% | 8.66% | Upgrade
|
| Return on Invested Capital (ROIC) | -5.69% | -3.16% | 14.95% | 13.63% | 41.83% | 25.59% | Upgrade
|
| Return on Capital Employed (ROCE) | -4.10% | -2.30% | 9.30% | 8.60% | 25.70% | 15.60% | Upgrade
|
| Earnings Yield | -1.94% | -0.69% | 5.24% | 3.66% | 8.50% | 3.62% | Upgrade
|
| FCF Yield | 6.38% | 1.73% | 0.41% | -0.78% | 7.80% | 1.19% | Upgrade
|
| Dividend Yield | 1.18% | 1.11% | 1.82% | 1.37% | 1.65% | 0.81% | Upgrade
|
| Payout Ratio | - | - | 34.93% | 46.75% | 11.73% | 27.38% | Upgrade
|
| Buyback Yield / Dilution | -1.43% | -4.45% | -4.71% | -0.36% | 0.44% | -0.74% | Upgrade
|
| Total Shareholder Return | -0.24% | -3.33% | -2.89% | 1.01% | 2.09% | 0.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.